Bio-Techne (TECH) Notes Payables (2014 - 2022)
Bio-Techne's (TECH) quarterly Notes Payables came in at $500000.0 in Q2 2022, down 37.5% year-on-year from $800000.0 in Q2 2021, and down 75.0% quarter-over-quarter from $2.0 million in Q1 2022.
Bio-Techne (TECH) Notes Payables (2014 - 2022) Analysis & Trends
Bio-Techne's Notes Payables history runs 6 years deep, the most recent figure standing at $500000.0 for Q2 2022.
- On a quarterly basis, Notes Payables fell 37.5% year-over-year to $500000.0 in Q2 2022; TTM through Jun 2022 was $500000.0, a 37.5% decrease from a year earlier, with the FY2022 full-year figure at $500000.0, down 37.5% from the prior year.
- Notes Payables eased to $500000.0 in Q2 2022 per TECH's latest filing, from $2.0 million in the prior quarter.
- Across five years, Notes Payables topped out at $2.0 million in Q1 2022 and bottomed at $200000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 500,000.00 |
| Mar 31, 2022 | 2.00 Mn |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 800,000.00 |
| Mar 31, 2017 | 14.58 Mn |
| Dec 31, 2016 | 3.60 Mn |
| Sep 30, 2016 | 3.73 Mn |
| Jun 30, 2016 | 3.76 Mn |
| Mar 31, 2016 | 3.81 Mn |
| Dec 31, 2015 | 3.79 Mn |
| Sep 30, 2015 | 3.87 Mn |
| Jun 30, 2015 | 4.02 Mn |
| Mar 31, 2015 | 3.00 Mn |
| Dec 31, 2014 | 5.98 Mn |
| Sep 30, 2014 | 5.95 Mn |
| Jun 30, 2014 | 5.95 Mn |